Replies to post #2423 on Idenix Pharmaceuticals (IDIX)

[DewDiligence]

IDIX Drug Portfolio



What’s changed relative to the prior
version of this chart six months ago?

Three things:

1. IDX184 for HCV has moved from preclinical into phase-1.

2. The HCV protease inhibitors now have names (IDX136, IDX316) and have moved closer to phase-1.

3. The HCV non-nucleoside polymerase inhibitor now has a name (IDX375) and has moved closer to phase-1.